Full text is available at the source.
Abstract
Glioblastomas (GBM) are the most common and aggressive primary malignant brain tumors in adults.
- The blood brain barrier (BBB) significantly limits the effectiveness of anti-cancer drugs for GBM treatment.
- Most GBMs recur after initial treatment, partly due to tumor cells being shielded from chemotherapy by the intact BBB.
- The existing literature on how chemotherapeutic agents pass through the BBB is inconsistent and insufficiently documented.
- Strategies to enhance the delivery of drugs across the BBB are being investigated.
- Improved understanding of drug passage through the BBB may help in developing more effective treatments.
Simplified